会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Systems and methods for the detection of biomarkers
    • 用于检测生物标志物的系统和方法
    • US08426151B2
    • 2013-04-23
    • US12906227
    • 2010-10-18
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • G01N33/53G01N31/00
    • G01N33/54393A61B10/0045C12Q1/40G01N33/50
    • System and methods for the detection of biomarkers. In at least one embodiment of a system for the detection of a diagnostic marker in a body fluid of the present disclosure, the system comprises a diagnostic device comprising a plurality of test wells, wherein each test well is capable of containing at least one detection agent, a detection device capable of interacting with the diagnostic device, wherein the detection device is capable of detecting an interaction between the at least one detection agent and a diagnostic marker in at least one of the plurality of test wells, and a stabilization agent contained within at least one of the plurality of test wells, the stabilization agent capable of completely or substantially preventing the degradation or inactivation of the detection agent or the diagnostic marker.
    • 用于检测生物标志物的系统和方法。 在用于检测本公开的体液中的诊断标记物的系统的至少一个实施方案中,该系统包括包含多个测试孔的诊断装置,其中每个测试孔能够含有至少一种检测剂 ,能够与所述诊断装置相互作用的检测装置,其中所述检测装置能够检测所述多个检测孔中的至少一个中的所述至少一个检测剂和诊断标记之间的相互作用,以及包含在所述检测装置内的稳定剂 多个测试孔中的至少一个,稳定剂能够完全或基本上防止检测剂或诊断标记的降解或失活。
    • 4. 发明申请
    • SYSTEMS AND METHODS OF ANALYZING BIOMARKER LEVELS
    • 分析生物标志物水平的系统和方法
    • US20110195858A1
    • 2011-08-11
    • US12906221
    • 2010-10-18
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • C40B30/04G01N33/53C12Q1/68
    • G01N33/54393A61B10/0045C12Q1/40G01N33/50
    • Systems and methods of analyzing biomarker levels. In at least one embodiment of a method of analyzing biomarker levels, the method comprises the steps of combining a body fluid comprising a diagnostic marker with a stabilization agent for an incubation period, introducing the stabilized body fluid into a detection platform, combining a detection agent with the stabilized body fluid, determining an interaction characteristic of the detection agent and the diagnostic marker of the stabilized body fluid using a detection device in communication with a processor, comparing the interaction characteristic with a plurality of indexed interaction records contained on a database in communication with the processor to determine an identity and concentration of the detection marker, generating a report of the identity and concentration of the detection marker in the body fluid, and delivering the report to a recipient.
    • 分析生物标志物水平的系统和方法。 在分析生物标志物水平的方法的至少一个实施方案中,该方法包括以下步骤:将包含诊断标记的体液与稳定剂组合用于潜伏期,将稳定的体液引入检测平台,组合检测剂 使用稳定的体液,使用与处理器通信的检测装置来确定所述检测剂和所述稳定体液的诊断标记物的相互作用特性,将所述交互特征与包含在通信数据库中的多个索引交互记录进行比较 处理器确定检测标记的身份和浓度,产生体液中检测标记的身份和浓度的报告,以及将报告递送给接收者。
    • 5. 发明申请
    • SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC POTENTIAL
    • 用于确定治疗潜力的系统和方法
    • US20110195851A1
    • 2011-08-11
    • US12906164
    • 2010-10-18
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • Richard H. SelinfreundRakesh VigRichard P. Gill
    • C40B30/02C40B60/14
    • G01N33/54393A61B10/0045C12Q1/40G01N33/50
    • Systems and methods for determining therapeutic potential. In at least one embodiment of a system of the present disclosure, the system comprises a detection platform, a computer processor and a database. The processor, in at least one embodiment of a method of the present disclosure, has and executes a software program operational to determine a binding characteristic of the detection agent and a stabilized diagnostic marker in each of the plurality of detection sites on the platform, compare the binding characteristic, and determining the stabilizing agent with the greatest effect on the binding characteristic between the detection agent and the diagnostic marker. Further, at least one embodiment of a system for determining the therapeutic potential of a therapeutic compound of the present disclosure is able to generate a binding record using the compared binding characteristics, and deliver the binding record to a recipient.
    • 用于确定治疗潜力的系统和方法。 在本公开的系统的至少一个实施例中,系统包括检测平台,计算机处理器和数据库。 在本公开的方法的至少一个实施例中,处理器具有并执行可操作的软件程序,以确定该平台上的多个检测位置中的每一个中的检测剂和稳定的诊断标记的结合特性,比较 结合特性,以及确定对检测剂和诊断标记之间的结合特性影响最大的稳定剂。 此外,用于确定本公开的治疗化合物的治疗潜力的系统的至少一个实施方案能够使用比较的结合特征产生结合记录,并将结合记录递送给接受者。